We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

59 hedge funds and large institutions have $225M invested in VanEck Pharmaceutical ETF in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $157M → $225M (+$68.1M)

20.11% more ownership

Funds ownership: 49.03% → 69.14% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less funds holding

Funds holding: 60 → 59 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

Holders
59
Holders Change
-1
Holders Change %
-1.67%
% of All Funds
1.55%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
14
Reduced
19
Closed
7
Calls
$261K
Puts
–
Net Calls
+$261K
Net Calls Change
-$476K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$23.2M
2
Bank of America
Bank of America
North Carolina
+$2.78M
3
LPL Financial
LPL Financial
California
+$927K
4
M&T Bank
M&T Bank
New York
+$875K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$537K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.59M
2
CS
Credit Suisse
Switzerland
-$4.68M
3
MIM
Macroview Investment Management
Maryland
-$2.84M
4
Jane Street
Jane Street
New York
-$2.45M
5
VF
Virtu Financial
New York
-$2.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASN
51
Advisory Services Network
Georgia
$50K +$65 +1 +0.1%
AIG
52
American International Group
New York
$41K -$89.8K -1,391 -69%
Simplex Trading
53
Simplex Trading
Illinois
$31K -$40.8K -632 -56%
CFA
54
Carroll Financial Associates
North Carolina
$13K – – –
FAM
55
Formidable Asset Management
Ohio
$12K – – –
IA
56
IFP Advisors
Florida
$10K +$9.69K +150 New
WEC
57
Winslow Evans & Crocker
Massachusetts
$6.53K – – –
US Bancorp
58
US Bancorp
Minnesota
$4K +$4.26K +66 New
VF
59
Virtu Financial
New York
– -$2.21M -35,076 Closed
EDRE
60
Edmond de Rothschild (Europe)
Luxembourg
– -$1.37M -21,770 Closed
EDRH
61
Edmond de Rothschild Holding
Switzerland
– -$1.37M -21,770 Closed
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
– -$1.28M -19,758 Closed
VKH
63
Virtu KCG Holdings
New York
– -$452K -7,179 Closed
RG
64
Redmile Group
California
– -$409K -6,500 Closed
RCG
65
Ruggie Capital Group
Florida
– -$301K -4,733 Closed
1 2
3

PPH Hedge Fund Activity: Q4 2015 in Review

59 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q4 2015, worth a combined $225M — up 43% from $157M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PPH and 6 opened new positions — a net loss of 1 holder — while 19 trimmed existing stakes and 14 added.

The largest buyer was Goldman Sachs, adding an estimated $23.2M. The largest seller was Morgan Stanley, cutting an estimated $5.59M.

  • 59 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q4 2015, down from 60 in Q3 2015.
  • Funds reported $225M of VanEck Pharmaceutical ETF stock for Q4 2015, up 43% quarter-over-quarter.
  • 6 funds opened new VanEck Pharmaceutical ETF positions in Q4 2015 and 7 closed out, a net change of -1 holder.
  • The largest VanEck Pharmaceutical ETF buyer in Q4 2015 was Goldman Sachs, an estimated $23.2M added.
  • The largest VanEck Pharmaceutical ETF seller in Q4 2015 was Morgan Stanley, an estimated $5.59M sold.

Based on aggregated 13F filings for Q4 2015.